Conducting research to elucidate nature’s mysteries is reward enough.

Tying federal research funding to scientists’ efforts to inform and engage the public can help fix widespread indifference to science.

At a time of fast-paced science and rampant misinformation, can we trust the non–peer-reviewed literature?

ASAPbio has developed resources for preprint servers, institutions, scientists, and journalists to promote the responsible reporting of research in the media.

Effectively relating science to the public is a science in itself, and expertise on a topic doesn’t guarantee expertise in explaining it.

As COVID-19 therapies get emergency-use green lights, the Biden administration must organize a therapeutic review board to help identify what’s working and what’s not.

Meet some of the people featured in the October 2020 issue of The Scientist.

Race has been used to segment humanity and, by extension, establish and enforce a hierarchy in science. Individual and institutional commitments to racial justice in the sciences must involve political activity.

Researchers have been forced to reckon with restrictions on lab access. Now is the time to figure out how to make science portable and widely accessible.

Fast science—with all its warts—is making unprecedented progress in the fight against COVID-19.

Despite high-profile political tensions between the two countries, researchers in the US and China are working together now more than ever, according to our bibliometric study.

What we can and must do to make science more equitable.

Accounting for a limited stockpile of cholera vaccine can provide insight into the most effective way to distribute future COVID-19 vaccines.

Our handbook on best practices for quality assurance in biomedicine can help funding agencies shore up research integrity—which is especially needed at a time when mistakes can have outsize effects.

Among the disruptions and pain caused by the COVID-19 pandemic, researchers are dealing with a sudden halt in in-person interactions.

If governments were to use SARS-CoV-2 antibody tests to manage who can re-enter the workplace, society must accept a sacrifice of privacy.

We mourned the closing of our lab. But then we got back to work—finding the balance between scholarly relevance and adapting to life in a world of new social norms.

Here’s how my group put our research on pause and how we’ve continued our work from home.

In the midst of a pandemic, individual patients are not always the focus of the ethics discussions.